Intellia Therapeutics
Price & Volume
Stats
See more52W Range | $5.90-$28.25 |
Market Cap | $1.5B |
Shares Short | 45M |
Financials
See moreRevenue (12 Mos) | $67.6M |
Revenue Growth (YoY) | 78.8% |
Gross Profit (12 Mos) | -$256.7M |
Diluted EPS | -$3.81 |
News
See moreYahoo Finance • 3 days ago
Roblox initiated, Target upgraded: Wall Street's top analyst calls
Yahoo Finance • 4 days ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Yahoo Finance • 7 days ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
Yahoo Finance • 9 days ago
Intellia outlines 2026 lonvo-z launch plans as FDA lifts clinical hold on MAGNITUDE-2
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 377 |
